EQUITY PURCHASE AGREEMENT by and among BAXTER INTERNATIONAL INC., SPRUCE BIDCO I INC., SPRUCE BIDCO II INC., SPRUCE BIDCO I LIMITED and CP SPRUCE HOLDINGS, S.C.Sp Dated as of August 12, 2024Equity Purchase Agreement • August 13th, 2024 • Baxter International Inc • Surgical & medical instruments & apparatus • New York
THIS EQUITY PURCHASE AGREEMENT (including the exhibits and schedules hereto, each as amended or restated from time to time, this “Agreement”), dated as of August 12, 2024 (the “Execution Date”), is made by and among Spruce Bidco I, Inc., a Delaware corporation (“US Bidco I”), Spruce Bidco II, Inc., a Delaware corporation (“US Bidco II”), Spruce Bidco I Limited, an Irish corporation (“Irish Bidco”), and CP Spruce Holdings, S.C.Sp, a Luxembourg special limited partnership (société en commandite spéciale) having its registered office at 2 avenue Charles de Gaulle, L-1653 Luxembourg and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B288011, represented by its managing general partner (associé commandité gérant) CP VIII Spruce GP S.à r.l., a Luxembourg private limited liability company (société à responsabilité limitée) having its registered office at 2 avenue Charles de Gaulle, L-1653 Luxembourg and registered wi
